Skip navigation
Dr Petr Zámostný

The GTP helps us to speed up tablet compression screening in reformulation projects aimed at replacing wet granulation by roller compaction

The University of Chemistry and Technology, Prague, is now using the Gamlen Tablet Press GTP-1 for both tablet compression research and undergraduate teaching.

Dr Petr Zámostný, Associate Professor, Department of Organic Technology, explains how the Gamlen Tablet Press is used in current research programmes at the University: “The GTP helps us to speed up tablet compression screening in reformulation projects aimed at replacing wet granulation by roller compaction and I am looking forward to the GTP-1 helping us in our research project involving the study of glidant action during the secondary compression of dry-granulated product.”

A small machine, with a footprint similar to an A4 sheet of paper, the Gamlen Tablet Press is safe to use and less complex than a full-scale tablet press; properties that are beneficial in an educational environment.
“I find the GTP-1 very useful for teaching undergraduate students the principles of tablet compression because of its easy operation and favourable size for bench-top placement” added Dr Zámostný.

The Gamlen Tablet Press is designed to operate in three easy steps; the user simply weighs the powder into a die using a conventional balance, compresses the tablet and then ejects the finished product ready for use. Entirely computer-controlled, it works at punch speeds of 1 mm/ second using a V-shape compression wave form. It can compress from 2 mg to 400 mg of material at punch sizes from 2 mm to 13 mm in diameter depending on the tablet weight required. The compression load is pre-set and reproducible ±1% between compressions.

For further information on the Gamlen Tablet Press visit: www.gamlentableting.com or telephone Gamlen Tableting Limited on: +44 (0)115 912 4271 to arrange a demonstration.

ENDS

Additional information

• Gamlen Tableting www.gamlen.co.uk was established in 2011 by Dr Michael Gamlen who has over 30 years’ experience on tablet development. Michael was Head of Tablet Development at The Wellcome Foundation for 15 years. He specialises in managing product development, formulation, and tablet and process development studies.

• Gamlen Tablet Presses have been purchased by organisations all over the world including Actavis UK Ltd, De Montfort University, UK, GlaxoSmithKline (GSK) UK and US, Jordanian Pharmaceutical Company, Massachusetts Institute of Technology (MIT) US, Imperial College, UK, Sawai Pharmaceuticals, Japan, Monash University, Australia and Reckitt Benckiser UK Ltd.

• Entirely computer-controlled, the Gamlen Tablet Press is a portable laboratory instrument that can be used for material characterisation, pre-formulation, formulation and process development, QbD for tablets and QC of incoming APIs and excipients. Data generated on the device can be directly translated to the production situation.

For corporate and sales enquiries or to request a demonstration, please contact:

Dr Michael Gamlen
Managing Director
Gamlen Tableting Limited

Registered office:
Biocity Nottingham
Pennyfoot Street
Nottingham
NG1 1GF
United Kingdom

London office and demonstration laboratory:
Yeoman House
63 Croydon Road
London
SE20 7TS
United Kingdom

Tel: +44 115 912 4271
Email: michael.gamlen@gamlentableting.com
Web: www.gamlentableting.com

For all editorial enquiries and photography please contact:

Philippa Bevan
Tel: +44 (0)1785 747 102
Email: philippa@accelerate-associates.co.uk

This press release was distributed by ResponseSource Press Release Wire on behalf of Gamlen Tableting in the following categories: Medical & Pharmaceutical, for more information visit http://pressreleasewire.responsesource.com/about.